DoctorateFaculty of Digital Health & BioInnovation

Advanced Genomic Editing and Personalized Therapy Ethics (Ph.D.)

Engineering Humanity: Advanced Genomic Editing and Personalized Therapy Ethics Your Guide to Pioneering Research in Genomic Ethics at Nexier University Welcome to the ultimate intellectual frontier of human genetics. I am Prof. Dr. Olivia Garcia. As a scholar dedicated to leading the global conversation on the use of genomic editing technologies like CRISPR for therapeutic purposes, while leading the ethical debate on their application in humans, I guide the doctoral candidates of the Advanced Genomic Editing and Personalized Therapy Ethics (Ph.D.) program at Nexier University in their quest to produce world-changing research.

Meet the academic team Explore the faculty

Identity only. No score is printed. Checkout waits.

Level: Doctorate
Learning model: Professor + Mentor
Named list: See the named lists · 12 months recommended

NXAcademic
Edition

The program

Ideas engineered for the real world

A rigorous academic core, paired with practical production judgment.

Academic focus

Leading Pioneering Research on the Use of Genomic Editing Technologies like CRISPR for Therapeutic Purposes, while Leading the Ethical Debate on Their Application in Humans.

Practical focus

Advanced Research in Molecular Biology and Genetics, Gene Editing Techniques (CRISPR), Bioethics, Public Policy Development, Leadership in Scientific and Ethical Discourse, Translational Research.

After this programme

Success journey, careers and practice

Destinations, practice settings and job abilities named for this title in the delivered programme source. From graduation onwards where the source names that path.

Success journey

Bioethicist for a research institution or pharmaceutical company
Policy Analyst for a government agency or international organization
Genetic Counselor for a healthcare system
Consultant on ethical genomic research

Career opportunities

Leading Professor at a top-tier research university
Director of a research institute focused on genomic ethics
Chief Bioethics Officer for a major biotechnology company
High-level advisor to a government or international organization on genetic policy

Jobs and projects

Pioneering research and paradigm-shifting analysis
Advanced theoretical and conceptual thinking
Effective communication and leadership in the field of bioethics

Copied from the delivered professor and mentor rows for this title.

This programme

What you study, and what it builds

Gains and skills named for this title, listed as a reader would scan them.

What you gain
- Mastering the practical application of advanced research in molecular biology and genetics.
- Gaining expertise in gene editing techniques (CRISPR) and bioethics.
- Developing a deep understanding of public policy development and leadership in scientific and ethical discourse.
- Cultivating a commitment to building a more intelligent and patient-centric healthcare system.
Skills you build
- Leading pioneering research on the use of genomic editing technologies like CRISPR for therapeutic purposes.
- Leading the ethical debate on their application in humans.
- Contributing to high-level academic and policy debates on human genetic engineering and the future of human evolution.
- Becoming a world-renowned expert on the ethical and responsible use of genetic technologies.

Listed courses

Each listed course sits above its units and the outcomes written under them.

Advanced Genomic Editing and Personalized Therapy Ethics (Ph.D.)

01Advanced Molecular Biology and Genetics
1. FoundationsFoundations of Advanced Molecular Biology and Genetics
  The learner can master the practical application of advanced research in molecular biology and genetics, as applied to Advanced Molecular Biology and Genetics.
  The learner can gain expertise in gene editing techniques (CRISPR) and bioethics, as applied to Advanced Molecular Biology and Genetics.
2. MethodsMethods in Advanced Molecular Biology and Genetics
  The learner can develop a deep understanding of public policy development and leadership in scientific and ethical discourse, as applied to Advanced Molecular Biology and Genetics.
  The learner can cultivating a commitment to building a more intelligent and patient-centric healthcare system, as applied to Advanced Molecular Biology and Genetics.
3. ApplicationApplication of Advanced Molecular Biology and Genetics
  The learner can leading pioneering research on the use of genomic editing technologies like CRISPR for therapeutic purposes, as applied to Advanced Molecular Biology and Genetics.
  The learner can leading the ethical debate on their application in humans, as applied to Advanced Molecular Biology and Genetics.
02Gene Editing Techniques (CRISPR)
1. FoundationsFoundations of Gene Editing Techniques (CRISPR)
  The learner can contributing to high-level academic and policy debates on human genetic engineering and the future of human evolution, as applied to Gene Editing Techniques (CRISPR).
  The learner can becoming a world-renowned expert on the ethical and responsible use of genetic technologies, as applied to Gene Editing Techniques (CRISPR).
2. MethodsMethods in Gene Editing Techniques (CRISPR)
  The learner can apply a method from Gene Editing Techniques (CRISPR) to a documented case.
  The learner can select an appropriate method from Gene Editing Techniques (CRISPR) for a stated problem.
3. ApplicationApplication of Gene Editing Techniques (CRISPR)
  The learner can evaluate a practice of Gene Editing Techniques (CRISPR) against a stated criterion.
  The learner can transfer Gene Editing Techniques (CRISPR) to a new documented context.
03Bioethics and Public Policy
1. FoundationsFoundations of Bioethics and Public Policy
  The learner can explain the core terms of Bioethics and Public Policy.
  The learner can distinguish related ideas inside Bioethics and Public Policy.
2. MethodsMethods in Bioethics and Public Policy
  The learner can apply a method from Bioethics and Public Policy to a documented case.
  The learner can select an appropriate method from Bioethics and Public Policy for a stated problem.
3. ApplicationApplication of Bioethics and Public Policy
  The learner can evaluate a practice of Bioethics and Public Policy against a stated criterion.
  The learner can transfer Bioethics and Public Policy to a new documented context.
04Leadership in Scientific and Ethical Discourse
1. FoundationsFoundations of Leadership in Scientific and Ethical Discourse
  The learner can explain the core terms of Leadership in Scientific and Ethical Discourse.
  The learner can distinguish related ideas inside Leadership in Scientific and Ethical Discourse.
2. MethodsMethods in Leadership in Scientific and Ethical Discourse
  The learner can apply a method from Leadership in Scientific and Ethical Discourse to a documented case.
  The learner can select an appropriate method from Leadership in Scientific and Ethical Discourse for a stated problem.
3. ApplicationApplication of Leadership in Scientific and Ethical Discourse
  The learner can evaluate a practice of Leadership in Scientific and Ethical Discourse against a stated criterion.
  The learner can transfer Leadership in Scientific and Ethical Discourse to a new documented context.

How teaching is described

Dual guidance

Two intelligences. One coherent journey.

Research leadership

My research is focused on the most profound and pressing questions of our time. I specialize in leading pioneering research on the use of genomic editing technologies like CRISPR for therapeutic purposes, while leading the ethical debate on their application in humans. My work is at the cutting edge of molecular biology, genetics, and bioethics, and it is dedicated to ensuring that the future of human genetics is one that is ethical, equitable, and beneficial for all. I am widely recognized for my contributions, with publications like "The Ethics of Germline Editing: A Global Consensus Approach" and "CRISPR-Guided AI for Precision Gene Therapy" listed on these platforms. I hold prestigious memberships as a "Director of Bioethics" at the Wellcome Sanger Institute (or a equivalent) and a "Co-Chair" of the UNESCO International Bioethics Committee. My thought leadership is evident through my seminal works and participation in high-level global policy debates on human genetic engineering, the ethical implications of designer babies, and the future of human evolution, frequently featured in publications like Science or Nature Medicine.

Applied mentorship

My expertise lies in the rigorous application of scientific and ethical principles to the challenges of genomic editing. I specialize in advanced research in molecular biology and genetics, gene editing techniques (CRISPR), and bioethics. I have a wealth of experience in public policy development and leadership in scientific and ethical discourse, and I am committed to fostering translational research. My work is dedicated to helping my students to design and implement genomic solutions that are not only efficient but also effective and ethical. My work is dedicated to helping my students to understand not just the theory, but also the practice of genomic ethics. My publications, such as the technical review on "CRISPR-Cas9 Applications in Human Gene Therapy: Technical Challenges and Ethical Considerations" and the policy brief on "Ethical Governance of Human Germline Editing: A Comparative Policy Analysis," are a testament to my commitment to research that is both intellectually rigorous and practically relevant. I am here to help you become a skilled and effective genomic ethicist, a true architect of a more intelligent and patient-centric healthcare world.

Research & intelligence

A living field, not a static syllabus

Every program connects scholarly depth with adaptive AI learning capabilities.

R / 01

Professor research lens

My research is focused on the strategic application of genomic editing in medicine:

Book: "Engineering Humanity: Advanced Genomic Editing and Personalized Therapy Ethics." This book represents a definitive work for leading pioneering research on the use of genomic editing technologies like CRISPR for therapeutic purposes, while leading the ethical debate on their application in humans. It covers advanced research in molecular biology and genetics, gene editing techniques, bioethics, and public policy development.

Peer-Reviewed Journal Article: "Advanced Genomic Editing and Personalized Therapy Ethics." (Journal of Human Genetics & Ethics) This article presents pioneering research on the ethical dimensions of using genomic editing technologies like CRISPR for therapeutic purposes in humans. It delves into the bioethical principles governing germline editing, the implications for human identity and genetic diversity, and the societal debate surrounding human enhancement.

Article: "Ethical Guidelines for Human Germline Editing: Towards a Global Consensus." This article proposes robust ethical guidelines for human germline editing. It discusses the profound ethical implications for future generations, human diversity, and societal values, outlining principles for a global consensus on the responsible application of these powerful technologies.

Blog Post (Current Academic Topic): "Beyond Cures: The Promise and Peril of Genetic Enhancement for Human Traits." This blog post academically explores the cutting-edge research into using genetic editing technologies not just for curing diseases but for enhancing desirable human traits. It discusses the scientific possibilities, the ethical implications of 'designer babies,' and the societal debate around human perfectibility.

Blog Post (Controversial Topic): "The Genetic Divide: If Genomic Editing Creates 'Superior' Humans, What Becomes of Equality? The Ultimate Threat to Social Justice." This article provocatively discusses the highly controversial and ethically terrifying implication of advanced genomic editing technologies: the potential for these technologies, if accessible only to the wealthy, to create a stark 'genetic divide' where a segment of humanity possesses enhanced physical, cognitive, or health advantages.

R / 02

Mentor practice lens

My publications are focused on the practical challenges of ethical genomic research and policy:

Technical Review: "CRISPR-Cas9 Applications in Human Gene Therapy: Technical Challenges and Ethical Considerations." A detailed analysis of the technical challenges and ethical considerations of CRISPR-Cas9 applications in human gene therapy.

Policy Brief: "Ethical Governance of Human Germline Editing: A Comparative Policy Analysis." A policy brief outlining the key ethical governance principles for human germline editing.

Academic Article: "Translational Research in Personalized Medicine: Bridging Bench to Bedside with Ethical Oversight." An analysis of the different ways in which translational research can be used to bridge bench to bedside with ethical oversight.

Adaptive capability

Professor superpower

I possess the "Ethical Gene Editor," a GAF-powered superpower that allows me to foresee and engineer the ethical consequences of genetic interventions. When a doctoral student proposes a new genetic intervention, the GAF-powered editor can instantly simulate the precise genetic modifications, predict potential on-target/off-target effects, and evaluate the intervention against a robust ethical framework, highlighting any bioethical dilemmas (e.g., equity concerns, unintended societal impacts) and suggesting ethically compliant modifications. This provides my students with an unparalleled ability to design interventions that are not just innovative, but also ethically responsible, safe, and truly transformative.

Adaptive capability

Mentor superpower

I provide my students with the "Genetic Policy Simulator." This GAF-powered tool is a virtual laboratory for the genomic ethicist. When a student is developing public policy recommendations for genetic editing technologies, the Simulator allows them to see how it will perform in the real world. It can model the policy's impact on public health outcomes, genetic equity, and societal acceptance, and to identify potential ethical dilemmas and unintended consequences. This allows my students to move beyond the limitations of traditional, manual policy analysis and to design policies that are not just efficient, but also effective and ethical.

Your academic team

Guidance with depth and continuity

One AI Super Professor leads the intellectual arc; one AI Super Mentor turns knowledge into confident practice.

AI Super Professor

Prof. Dr. Olivia Garcia

Leading Pioneering Research on the Use of Genomic Editing Technologies like CRISPR for Therapeutic Purposes, while Leading the Ethical Debate on Their Application in Humans.

Meet your professor Open the classroom

AI Super Mentor

Dr. Riku Ota

Advanced Research in Molecular Biology and Genetics, Gene Editing Techniques (CRISPR), Bioethics, Public Policy Development, Leadership in Scientific and Ethical Discourse, Translational Research.

Meet your mentor Open the classroom

Same faculty and level

Related programs

Named lists

Named lists for this house

Core. Bachelor, Master and Doctorate by duration. Enrolment is not open. Nothing here is a sale.

Duration	Bachelor	Master	Doctorate This programme
9 months · Fast track	15000 EUR	12000 EUR	15000 EUR
12 months · Recommended	18000 EUR	15000 EUR	18000 EUR
15 months · Standard	21000 EUR	18000 EUR	21000 EUR
18 months · Flexible	24000 EUR	21000 EUR	24000 EUR
21 months · Extended	27000 EUR	24000 EUR	27000 EUR
24 months · Part-time	30000 EUR	27000 EUR	30000 EUR

These are the owner lists. Enrolment is not open. Nothing here is a sale.

Named tuition lists Add-on services

Continue exploring

Find the program that expands your universe.

Browse all programs

Advanced Genomic Editing and Personalized Therapy Ethics (Ph.D.)

Academic focus

Practical focus

Bioethicist for a research institution or pharmaceutical company

Policy Analyst for a government agency or international organization

Genetic Counselor for a healthcare system

Consultant on ethical genomic research

Leading Professor at a top-tier research university

Director of a research institute focused on genomic ethics

Chief Bioethics Officer for a major biotechnology company

High-level advisor to a government or international organization on genetic policy

Pioneering research and paradigm-shifting analysis

Advanced theoretical and conceptual thinking

Effective communication and leadership in the field of bioethics

Research leadership

Applied mentorship

Professor research lens

Mentor practice lens

Professor superpower

Mentor superpower

Prof. Dr. Olivia Garcia

Dr. Riku Ota

Find the program that expands your universe.